Piper Sandler Maintains Overweight on Harpoon Therapeutics, Lowers Price Target to $15
Piper Sandler analyst Joseph Catanzaro maintains Harpoon Therapeutics (NASDAQ:HARP) with a Overweight and lowers the price target from $27 to $15.
HC Wainwright & Co. Maintains Buy on Harpoon Therapeutics, Lowers Price Target to $18
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Harpoon Therapeutics (NASDAQ:HARP) with a Buy and lowers the price target from $31 to $18.
94 Biggest Movers From Friday
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
50 Stocks Moving In Friday’s Mid-Day Session
Gainers
Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday.
Harpoon Therapeutics Discontinues Its Once Lead Prostate Cancer Candidate
Harpoon Therapeutics Inc (NASDAQ: HARP), in its
Harpoon Therapeutics Q4 EPS $(0.66) Down From $(0.45) YoY, Sales $4.30M Down From $7.49M YoY
Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.66) per share. This is a 46.67 percent decrease over losses of $(0.45) per share from the same period last year. The company reported $4.30 million in
68 Biggest Movers From Yesterday
Gainers
ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
41 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday.
Harpoon Therapeutics Granted FDA Orphan Drug Designation Monday for Treatment for Small Cell Lung Cancer
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=864721
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows.